phenylalanine has been researched along with Melanoma in 107 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 50 (46.73) | 18.7374 |
1990's | 24 (22.43) | 18.2507 |
2000's | 17 (15.89) | 29.6817 |
2010's | 10 (9.35) | 24.3611 |
2020's | 6 (5.61) | 2.80 |
Authors | Studies |
---|---|
Fukuda, H | 1 |
Du, J; Fan, Z; Lv, M; Sun, M; Wang, C | 1 |
Bahrami, K; Järvinen, J; Rautio, J; Srisongkram, T; Timonen, J; Weerapreeyakul, N | 1 |
Abe, Y; Fujii, R; Igaki, H; Imahori, Y; Itami, J; Kurihara, H; Morita, T; Nakamura, M; Nakamura, S; Nakayama, Y; Nishioka, S; Okamoto, H | 1 |
Date, H; Fukunaga, H; Matsuya, Y; Omura, M | 1 |
Fukuda, H; Hiratsuka, J | 1 |
Arai, Y; Hatazawa, J; Hiroi, K; Honda, N; Igaki, H; Itami, J; Kurihara, H; Morita, T | 1 |
Barth, RF; Chandra, S; Haider, SA; Huo, T; Kabalka, GW; Shaikh, AL; Yang, W | 1 |
Altevogt, P; Arnold, A; Cerwenka, A; Fiegler, N; Moldenhauer, G; Paschen, A; Rose-John, S; Schlecker, E; Sucker, A; Textor, S; von Strandmann, EP | 1 |
Casal, M; Dagrosa, MA; Juvenal, GJ; Navarro, A; Pisarev, MA; Portu, A; Rossini, AE; Saint Martin, G; Thorp, S | 1 |
Li, Z; Pan, LL; Zhang, FL; Zhang, ZZ; Zhu, XL | 1 |
Barth, RF | 1 |
Brandizzi, D; Cabrini, R; Carpano, M; Dagrosa, MA; Juvenal, GJ; Nievas, S; Olivera, M; Perona, M; Pisarev, M; Rodriguez, C; Santa Cruz, GA | 1 |
Casolaro, M; Cini, R; Del Bello, B; Ferrali, M; Maellaro, E | 1 |
Blaumann, H; Calzetta Larrieu, OA; Casal, MR; Feld, DB; Fernández, C; González, SJ; Jiménez Rebagliati, R; Kessler, J; Liberman, SJ; Longhino, J; Menéndez, PR; Nievas, SI; Pereira, MD; Roth, BM; Santa Cruz, GA | 1 |
Altieri, S; Cionini, L; Menichetti, L; Minn, H; Salvadori, PA; Sauerwein, WA; Solin, O | 1 |
Arnopolskaya, AM; Khokhlov, VF; Kozlovskaya, NG; Kulakov, VN; Mitin, VN; Portnov, AA; Sheino, IN; Zaitsev, KN | 1 |
Austin, B; Ghodousi, A; Hansen, D; Jamil, A; Skibo, EB | 1 |
Bitar, RA; Cartaxo, SB; Enokihara, MM; Ferreira, LM; Martin, AA; Martinho, Hda S; Oliveira, AF; Santos, ID | 1 |
Cabrini, RL; Carpano, M; Dagrosa, A; Portu, A; Saint Martin, G | 1 |
CREECH, O; KREMENTZ, ET; RYAN, RF | 1 |
HOLLAND, JF; REGELSON, W | 1 |
BOYLEN, JB; QUASTEL, JH | 1 |
CLARK, RL; SMITH, JL; STEHLIN, JS | 1 |
FOX, WW; HAWKINS, RA; SCANLON, EF; SMITH, WS | 1 |
RILEY, V | 1 |
Bannink, M; Eggermont, AM; Fekkes, D; Kruit, WH; Mulder, PG; Stoter, G; Van Gool, AR; van Ojik, HH | 1 |
Binns, PJ; Coderre, JA; Harling, OK; Hopewell, JW; Kiger, WS; Riley, KJ; Turcotte, JC | 1 |
Liu, H; Meadows, GG; Núñez, NP | 1 |
Blagoeva, PM | 1 |
Ichihashi, M; Mishima, Y; Tsuji, M | 1 |
Farishian, RA; Whittaker, JR | 2 |
Klein, LE; Nordlund, JJ | 1 |
Meadows, GG; Pierson, HF | 2 |
Ichihashi, M; Mishima, Y; Nakanishi, T | 1 |
Abdallah, RM; Desai, PR; Meadows, GG; Pierson, HF | 1 |
Beekhuis, H; Oldhoff, J; Oosterhuis, JW; Schraffordt Koops, H; van der Ploeg, E; Vermey, A | 1 |
Honda, C; Ichihashi, M; Mishima, Y; Wadabayashi, N | 1 |
Carlsson, J; Larsson, BS; Lindström, P; Olsson, P; Pettersson, OA; Sjöberg, S | 1 |
Feinendegen, LE; Müller-Gärtner, HW; Papaspyrou, M | 1 |
Fukuda, H; Ichihashi, M; Mishima, Y | 1 |
Bailey, MQ; Barth, RF; Coderre, JA; Matalka, KZ; Moeschberger, ML; Rofstad, EK; Soloway, AH; Staubus, AE | 2 |
Allen, BJ; Jones, R; Mallesch, JL; McCarthy, WH; Moore, DE; Stening, WA | 1 |
Abe, Y; Fukuda, H; Hiratsuka, J; Honda, C; Ichihashi, M; Kanda, K; Karashima, H; Kobayashi, T; Takahashi, J; Yoshino, K | 1 |
Carlsson, J; Lindström, P; Olsson, P; Pettersson, OA; Sjöberg, S | 1 |
Bartelink, H; Begg, AC; Gregoire, V; Huiskamp, R; Verrijk, R | 1 |
Bartfai, T; Berthold, M; Kahl, U; Kask, K; Nordvall, G | 1 |
Ichihashi, M; Kobayashi, T; Mizuma, N; Tano, K; Utsumi, H | 1 |
Hiratsuka, J; Honda, C; Ido, T; Imahori, Y; Mishima, Y; Ueda, S | 1 |
McCann, PP; Rasmussen, HS | 1 |
Burgaud, JL; Fehrentz, JA; Martinez, J; Nahon, JL; Poosti, R | 1 |
Fu, YM; Li, YQ; Meadows, GG | 1 |
Ferrans, VJ; Fu, YM; Meadows, GG; Pelayo, BA; Yu, ZX | 1 |
Abe, Y; Akaizawa, T; Fukuda, H; Hiratsuka, J; Honda, C; Ichihashi, M; Kobayashi, T; Mishima, Y; Takahashi, J; Wadabayashi, N; Yoshino, K | 1 |
Bendel, P; Kabalka, GW; Panov, V; Salomon, Y | 1 |
Kondoh, H; Mishima, Y | 1 |
Fu, YM; Meadows, GG; Pelayo, BA | 2 |
Busse, PM; Kiger, WS; Palmer, MR; Riley, KJ; Zamenhof, RG | 1 |
Hansson, J; Omholt, K; Platz, A; Ringborg, U | 1 |
Cassapo, R; Castro, M; Chaveca, T; Fernandes, AP; Gonçalves, IC; Oliveira, NG; Rodrigues, AS; Rueff, J; Toscano-Rico, JM | 1 |
Ge, X; Meadows, GG; Zhang, H | 1 |
Barth, RF; Bartus, RT; Coderre, JA; Ferketich, AK; Moeschberger, ML; Nawrocky, MM; Rofstad, EK; Rotaru, JH; Yang, W | 1 |
Campbell, IT; Harvie, MN; Howell, A; Thatcher, N | 1 |
Fu, YM; Ge, X; Li, YQ; Meadows, GG | 1 |
Breakefield, XO; Castiglione, CM; Halaban, R; Pawelek, J; Shiman, R | 1 |
Jensen, OA | 1 |
Watson, PG | 1 |
Stoetzel, GA; Traub, RJ; Vetter, RJ | 1 |
Eibergen, R; Oldhoff, J; Schraffordt Koops, H; van der Ploeg, E; Vermey, A | 1 |
DiGiovanni, J; Elmer, GW; Meadows, GG; Minor, L | 1 |
Abbé, JC; Belkhou, R; Dreyfus, H; Massarelli, R; Meyer, L; Mykita, S; Sahel, J | 1 |
Mishima, Y | 1 |
Slominski, A | 1 |
Hatta, S; Honda, C; Ichihashi, M; Mishima, Y | 1 |
Barth, RF; Fairchild, RG; Soloway, AH | 1 |
Allen, BJ; Brown, JK | 1 |
Allen, BJ; Coates, AS; Ichihashi, M; Mameghan, H; McCarthy, WH; Mishima, Y | 1 |
Abdallah, RM; Aslakson, CJ; Meadows, GG; Starkey, JR | 1 |
Coderre, JA; Cohen, S; Fairchild, RG; Fand, I; Glass, JD; Roy, U | 1 |
Abdallah, RM; Meadows, GG; Starkey, JR | 1 |
Acosta, PB; Bleier, JC; Heymsfield, SB; Lawson, DH; Nixon, DW; Stockton, LH | 1 |
Rorsman, H; Rosengren, AM; Rosengren, E | 1 |
Balda, BR; Birkmayer, GD | 4 |
Edmund, J; Egeberg, J; Jensen, OA | 4 |
Blois, MS | 1 |
Gruhn, WB; Maurer, LH; Pomeroy, JS | 1 |
Abell, MR; Fenn, ME | 1 |
Doores, L; Schulman, JD; Silagi, S; Wrathall, JR | 1 |
Burdette, WJ | 1 |
Clark, RL; McBride, CM | 1 |
Demopoulos, HB; Duke, PS; Yuen, TG | 1 |
Harris, EB; Kirchheimer, WF; Prabhakaran, K | 1 |
Brown, J; Gaudin, D; Stabler, A; Yielding, KL | 1 |
Beierwaltes, WH; Counsell, RE; Lieberman, LM; Varma, VM | 1 |
Demopoulos, HB | 2 |
Crawhall, JC; Hayward, BJ; Lewis, CA | 1 |
5 review(s) available for phenylalanine and Melanoma
Article | Year |
---|---|
Boron Neutron Capture Therapy (BNCT) for Cutaneous Malignant Melanoma Using
Topics: Boron Compounds; Boron Neutron Capture Therapy; Clinical Trials as Topic; Humans; Melanoma; Melanoma, Cutaneous Malignant; Phenylalanine; Radiobiology; Relative Biological Effectiveness; Skin Neoplasms | 2021 |
Pharmacokinetics of
Topics: Boron; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Glioblastoma; Humans; Isotopes; Melanoma; Neoplasms; Phenylalanine; Positron-Emission Tomography | 2020 |
Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Colorectal Neoplasms; Enzyme Inhibitors; Female; Hemangioma; Humans; Hydroxamic Acids; Melanoma; Metalloendopeptidases; Mice; Ovarian Neoplasms; Pancreatic Neoplasms; Phenylalanine; Protease Inhibitors; Skin Neoplasms; Thiophenes | 1997 |
A post melanosomal era: control of melanogenesis and melanoma growth.
Topics: Adolescent; Animals; Boron; Boron Compounds; Cricetinae; Fatty Acids, Unsaturated; Gene Expression Regulation, Neoplastic; Hair Color; Humans; Infant, Newborn; Isotopes; Male; Melanins; Melanocytes; Melanoma; Melanoma, Experimental; Models, Biological; Monophenol Monooxygenase; Neoplasm Proteins; Neutrons; Phenylalanine; Pigmentation Disorders; Protein Processing, Post-Translational; Pyrones; Radiation-Sensitizing Agents; Skin Pigmentation; Subcellular Fractions; Swine | 1992 |
Current progress in the management of cancer. A collective review.
Topics: Adenocarcinoma; Angiography; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Division; Chemotherapy, Cancer, Regional Perfusion; DNA, Neoplasm; Female; Fluorouracil; Head; Head and Neck Neoplasms; Humans; Lymphography; Lymphoma, Non-Hodgkin; Male; Mammography; Melanoma; Mustard Compounds; Neoplasms; Phenylalanine; Radioisotopes; Radionuclide Imaging; Radiotherapy Dosage; Selenium; Skin Neoplasms; Thermography; Time Factors | 1969 |
8 trial(s) available for phenylalanine and Melanoma
Article | Year |
---|---|
Dynamic changes in
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Boranes; Boron Neutron Capture Therapy; Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Head and Neck Neoplasms; Humans; Male; Melanoma; Middle Aged; Patient Selection; Phenylalanine; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Young Adult | 2018 |
BNCT for skin melanoma in extremities: updated Argentine clinical results.
Topics: Aged; Argentina; Boron Compounds; Boron Neutron Capture Therapy; Female; Humans; Leg; Male; Melanoma; Middle Aged; Phenylalanine; Radiation-Sensitizing Agents; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Skin Neoplasms | 2009 |
Pegylated interferon-alpha2b treatment in melanoma patients: influence on amino acids, 5-hydroxyindolacetic acid and pteridine plasma concentrations.
Topics: Adult; Aged; Amino Acids; Biopterins; Drug Administration Schedule; Female; Humans; Hydroxyindoleacetic Acid; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Melanoma; Middle Aged; Neopterin; Phenylalanine; Pilot Projects; Polyethylene Glycols; Pteridines; Randomized Controlled Trials as Topic; Recombinant Proteins; Time Factors; Tryptophan; Tyrosine | 2004 |
Tolerance of normal human brain to boron neutron capture therapy.
Topics: Boron Compounds; Boron Neutron Capture Therapy; Brain; Brain Neoplasms; Disorders of Excessive Somnolence; Glioblastoma; Humans; Melanoma; Phenylalanine; Radiation Tolerance | 2004 |
Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin.
Topics: Aged; Boron Compounds; Boron Neutron Capture Therapy; Female; Humans; Male; Melanoma; Middle Aged; Phenylalanine; Radiation-Sensitizing Agents; Radiotherapy Dosage; Skin; Skin Neoplasms | 1994 |
A pharmacokinetic model for the concentration of 10B in blood after boronophenylalanine-fructose administration in humans.
Topics: Adult; Aged; Boron; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Female; Fructose; Glioblastoma; Humans; Infusions, Intravenous; Male; Melanoma; Middle Aged; Models, Biological; Phenylalanine; Skin Neoplasms | 2001 |
Dose fractionation in neutron capture therapy for malignant melanoma.
Topics: Antibodies, Monoclonal; Cell Cycle; Clinical Trials as Topic; Humans; Melanoma; Neutrons; Phenylalanine; Radiotherapy | 1989 |
Thermal neutron capture therapy: the Japanese-Australian clinical trial for malignant melanoma.
Topics: Australia; Clinical Trials as Topic; Humans; Isotopes; Japan; Melanoma; Multicenter Studies as Topic; Neutrons; Phenylalanine; Radiotherapy; Skin Neoplasms | 1989 |
94 other study(ies) available for phenylalanine and Melanoma
Article | Year |
---|---|
Intracellular Self-Assembly of Peptides to Induce Apoptosis against Drug-Resistant Melanoma.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; G2 Phase Cell Cycle Checkpoints; Humans; Melanoma; Monophenol Monooxygenase; Peptides; Phenylalanine | 2022 |
Development of Sesamol Carbamate-L-Phenylalanine Prodrug Targeting L-Type Amino Acid Transporter1 (LAT1) as a Potential Antiproliferative Agent against Melanoma.
Topics: Amino Acids; Benzodioxoles; Biological Transport; Carbamates; HEK293 Cells; Humans; Large Neutral Amino Acid-Transporter 1; Leucine; Melanoma; Phenols; Phenylalanine; Prodrugs; Syndrome | 2022 |
Comparison of
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Boron Compounds; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Phenylalanine; Positron-Emission Tomography; Young Adult | 2020 |
A Model for Estimating Dose-Rate Effects on Cell-Killing of Human Melanoma after Boron Neutron Capture Therapy.
Topics: Boron; Boron Compounds; Boron Neutron Capture Therapy; Cell Death; Cell Line, Tumor; Cell Survival; Cobalt Radioisotopes; Computer Simulation; Dose-Response Relationship, Radiation; Gamma Rays; Humans; Isotopes; Melanoma; Models, Biological; Monte Carlo Method; Neutrons; Phenylalanine; Radiometry; Relative Biological Effectiveness; Time Factors | 2020 |
Effects of l-DOPA pre-loading on the uptake of boronophenylalanine using the F98 glioma and B16 melanoma models.
Topics: Animals; Boron Compounds; Brain Neoplasms; Drug Synergism; Female; Glioma; Levodopa; Melanoma; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Organ Specificity; Phenylalanine; Premedication; Tissue Distribution; Treatment Outcome | 2014 |
Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30.
Topics: ADAM Proteins; ADAM10 Protein; ADAM17 Protein; Amyloid Precursor Protein Secretases; B7 Antigens; Cell Line, Tumor; Dipeptides; HCT116 Cells; HeLa Cells; Humans; Hydroxamic Acids; Killer Cells, Natural; Lymphocyte Activation; MCF-7 Cells; Melanoma; Membrane Proteins; Natural Cytotoxicity Triggering Receptor 3; Phenylalanine; Protease Inhibitors; RNA Interference; RNA, Messenger; RNA, Small Interfering; Thiophenes; Tumor Escape; Up-Regulation | 2014 |
Assessment of biological effectiveness of boron neutron capture therapy in primary and metastatic melanoma cell lines.
Topics: Autoradiography; Biological Transport; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Humans; Intracellular Space; Melanoma; Neoplasm Metastasis; Phenylalanine; Radiation Tolerance; Relative Biological Effectiveness | 2015 |
Preparation and characterization of injectable Mitoxantrone poly (lactic acid)/fullerene implants for in vivo chemo-photodynamic therapy.
Topics: Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Combined Modality Therapy; Drug Carriers; Drug Liberation; Fullerenes; Injections; Lactic Acid; Male; Melanoma; Mice; Microspheres; Mitoxantrone; Phenylalanine; Photochemotherapy; Polyesters; Polymers; Xenograft Model Antitumor Assays | 2015 |
From the laboratory to the clinic: How translational studies in animals have lead to clinical advances in boron neutron capture therapy.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Melanoma; Phenylalanine; Translational Research, Biomedical | 2015 |
Experimental Studies of Boronophenylalanine ((10)BPA) Biodistribution for the Individual Application of Boron Neutron Capture Therapy (BNCT) for Malignant Melanoma Treatment.
Topics: Animals; Body Temperature; Boron; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Humans; Ki-67 Antigen; Melanoma; Melanoma, Cutaneous Malignant; Mice; Mice, Nude; Phenylalanine; Platelet Endothelial Cell Adhesion Molecule-1; Radioisotopes; Skin Neoplasms; Tissue Distribution; Tumor Burden | 2015 |
Cisplatin/hydrogel complex in cancer therapy.
Topics: Acrylamides; Antineoplastic Agents; Cisplatin; Delayed-Action Preparations; Dimethyl Sulfoxide; Drug Carriers; Drug Delivery Systems; Histidine; Humans; Hydrogels; Melanoma; Phenylalanine; Polymers; Skin Neoplasms; Tumor Cells, Cultured; Water | 2009 |
Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT.
Topics: Boron; Boron Compounds; Boron Neutron Capture Therapy; Fluorine Radioisotopes; Humans; Isotopes; Lymphatic Metastasis; Melanoma; Models, Biological; Neoplasms; Phenylalanine; Positron-Emission Tomography; Prognosis; Radiation-Sensitizing Agents; Tomography, X-Ray Computed | 2009 |
Comparison of BNCT and GdNCT efficacy in treatment of canine cancer.
Topics: Animals; Bone Neoplasms; Boron Compounds; Boron Neutron Capture Therapy; Combined Modality Therapy; Dog Diseases; Dogs; Gadolinium; Humans; Melanoma; Mouth Neoplasms; Neoplasms; Neutron Capture Therapy; Osteosarcoma; Phenylalanine | 2009 |
Triple molecular target approach to selective melanoma cytotoxicity.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Catalytic Domain; Cell Line, Tumor; Humans; IMP Dehydrogenase; Lung Neoplasms; Melanoma; Mice; Mice, SCID; Models, Molecular; Phenylalanine; Pyrroles; Quantitative Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2010 |
Differential diagnosis in primary and metastatic cutaneous melanoma by FT-Raman spectroscopy.
Topics: Amides; Diagnosis, Differential; DNA; Humans; Melanoma; Phenylalanine; Skin; Skin Neoplasms; Spectrum Analysis, Raman | 2010 |
Qualitative autoradiography with polycarbonate foils enables histological and track analyses on the same section.
Topics: Animals; Autoradiography; Boranes; Boron; Humans; Liver; Melanoma; Mice; Mice, Nude; Neoplasms, Experimental; Phenylalanine; Polycarboxylate Cement | 2013 |
Treatment of melanoma by isolation-perfusion technique.
Topics: Humans; Leg; Mechlorethamine; Melanoma; Neoplasms; Nitrogen Mustard Compounds; Perfusion; Phenylalanine | 1959 |
Studies of phenylalanine nitrogen mustard (CB 3025) in metastatic malignant melanoma of man.
Topics: Humans; Mechlorethamine; Melanoma; Nitrogen Mustard Compounds; Phenylalanine | 1958 |
Effects of L-phenylalanine and sodium phenylpyruvate on the formation of melanin from L-tyrosine in melanoma.
Topics: Melanins; Melanoma; Phenylalanine; Phenylpyruvic Acids; Sodium; Tyrosine | 1962 |
HISTOPATHOLOGICAL CHANGES IN MALIGNANT MELANOMA AND NORMAL TISSUES FOLLOWING REGIONAL PERFUSION WITH L-PHENYLALANINE MUSTARD (L-SARCOLYSIN).
Topics: Chemotherapy, Cancer, Regional Perfusion; Extracorporeal Circulation; Lymphatic Metastasis; Melanoma; Melphalan; Mice; Mustard Plant; Neoplasms; Neoplasms, Experimental; Pharmacology; Phenylalanine; Research | 1964 |
FATAL HOMOTRANSPLANTED MELANOMA: A CASE REPORT.
Topics: Humans; Melanoma; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Pathology; Phenylalanine; Transplantation, Homologous | 1965 |
Salt inhibition and enhancement of cytochrome, succinic, and dopa oxidase systems of mouse melanomas.
Topics: Cytochromes; Melanoma; Monophenol Monooxygenase; Neoplasms; Oxidoreductases; Phenylalanine; Salts | 1950 |
PPAR-gamma ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells.
Topics: Amino Acids; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Hypoglycemic Agents; Immunologic Factors; Ligands; Male; Melanoma; Methionine; Phenylalanine; PPAR gamma; Prostaglandin D2; Prostatic Neoplasms; Thiazolidinediones; Tyrosine | 2006 |
Aminoacids--precursors of melanin synthesis in hamster melanoma.
Topics: Amino Acids; Animals; Cricetinae; Ferrous Compounds; Iron; Levodopa; Male; Melanins; Melanoma; Mesocricetus; Neoplasm Transplantation; Phenylalanine; Tryptophan; Tyrosine | 1984 |
[Selective affinity of 10B1-paraboronophenylalanine-HCl to malignant melanoma: thermal neutron capture therapy].
Topics: Animals; Boron; Boron Compounds; Cricetinae; Isotopes; Melanoma; Neoplasms, Experimental; Neutrons; Phenylalanine; Skin; Skin Neoplasms; Spectrometry, Gamma | 1983 |
Phenylalanine lowers melanin synthesis in mammalian melanocytes by reducing tyrosine uptake: implications for pigment reduction in phenylketonuria.
Topics: Animals; Cricetinae; Humans; Melanins; Melanocytes; Melanoma; Monophenol Monooxygenase; Neoplasms, Experimental; Phenylalanine; Phenylketonurias; Skin Neoplasms; Skin Pigmentation; Tyrosine | 1980 |
Genetic basis of pigmentation and its disorders.
Topics: Albinism; Animals; Cell Differentiation; Color; Humans; Lentigo; Melanins; Melanocytes; Melanoma; Mice; Monophenol Monooxygenase; Nevus; Phenylalanine; Pigmentation; Pigmentation Disorders; Skin; Syndrome; Tyrosine | 1981 |
Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma.
Topics: Animals; Antineoplastic Agents; Ascorbic Acid; Carbidopa; Cell Line; Diet; Drug Synergism; Drug Therapy, Combination; Female; Injections, Intraperitoneal; Levodopa; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Phenylalanine; Tyrosine | 1983 |
Specific killing effect of 10B1-para-boronophenylalanine in thermal neutron capture therapy of malignant melanoma: in vitro radiobiological evaluation.
Topics: Boron Compounds; Cell Survival; Cells, Cultured; Culture Media; Humans; In Vitro Techniques; Melanoma; Neutrons; Phenylalanine; Premedication; Radiation-Sensitizing Agents; Skin Neoplasms | 1982 |
Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopa-levodopa methyl ester chemotherapy.
Topics: Animals; Carbidopa; Diet; Drug Evaluation, Preclinical; Female; Levodopa; Melanoma; Mice; Neoplasms, Experimental; Phenylalanine; Tyrosine | 1982 |
Local recurrence and survival in patients with (Clark Level IV/V and over 1.5-mm thickness) stage I malignant melanoma of the extremities after regional perfusion.
Topics: Chemotherapy, Cancer, Regional Perfusion; Female; Humans; Male; Melanoma; Neoplasm Recurrence, Local; Phenylalanine; Prognosis; Sex Factors; Skin Neoplasms | 1981 |
Selective boron accumulation in human ocular melanoma vs surrounding eye components after 10B1-p-boronophenylalanine administration. Prerequisite for clinical trial of neutron-capture therapy.
Topics: Boron; Boron Compounds; Clinical Trials as Topic; Eye Neoplasms; Humans; Isotopes; Mass Spectrometry; Melanoma; Neutron Capture Therapy; Phenylalanine; Radiation-Sensitizing Agents | 1994 |
Cellular binding of carboranylalanine and some effects of boron neutron capture. Analysis of cultured melanoma B16 cells.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cell Survival; Glioma; Humans; Melanins; Melanoma; Melanoma, Experimental; Phenylalanine; Protein Binding; Tumor Cells, Cultured | 1994 |
Preloading with L-tyrosine increases the uptake of boronophenylalanine in mouse melanoma cells.
Topics: Animals; Boron; Boron Compounds; Boron Neutron Capture Therapy; Melanoma; Mice; Phenylalanine; Radiation-Sensitizing Agents; Time Factors; Tumor Cells, Cultured; Tyrosine | 1994 |
[Neutron capture therapy for cancer].
Topics: Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Humans; Infusions, Intravenous; Melanoma; Phenylalanine; Skin Neoplasms | 1994 |
A nude rat model for neutron capture therapy of human intracerebral melanoma.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Brain; Brain Neoplasms; Female; Humans; Male; Melanoma; Mice; Middle Aged; Neoplasm Transplantation; Phenylalanine; Rats; Rats, Nude; Tumor Cells, Cultured | 1994 |
The pharmacokinetics of p-Boronophenylalanine.fructose in human patients with glioma and metastatic melanoma.
Topics: Boron; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Glioma; Humans; Melanoma; Phenylalanine; Radiation-Sensitizing Agents | 1994 |
Penetration and binding of L- and D-carboranylalanine in human melanoma spheroids.
Topics: Boron Compounds; Boron Neutron Capture Therapy; Cell Aggregation; Cell Cycle; Humans; Melanoma; Phenylalanine; Radiation-Sensitizing Agents; Stereoisomerism; Thymidine; Tritium; Tumor Cells, Cultured | 1993 |
Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent.
Topics: Animals; Boron; Boron Compounds; Boron Neutron Capture Therapy; Brain; Brain Neoplasms; Cell Survival; Humans; Male; Melanoma; Middle Aged; Phenylalanine; Radiation-Sensitizing Agents; Radiotherapy Dosage; Rats; Rats, Nude; Tissue Distribution | 1993 |
Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors.
Topics: Animals; Boric Acids; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Brain; Dose-Response Relationship, Drug; Female; Half-Life; Injections, Intraperitoneal; Kidney; Liver; Male; Melanoma; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred Strains; Phenylalanine; Radiation-Sensitizing Agents; Sarcoma, Experimental; Sulfhydryl Compounds; Time Factors | 1993 |
Delineation of the peptide binding site of the human galanin receptor.
Topics: Alanine; Amino Acid Sequence; Animals; Binding Sites; Cell Membrane; Cloning, Molecular; Conserved Sequence; DNA, Complementary; Galanin; Glycine; Histidine; Humans; Hydrogen Bonding; Kinetics; Ligands; Melanoma; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Phenylalanine; Point Mutation; Polymerase Chain Reaction; Protein Structure, Secondary; Receptors, Galanin; Receptors, Gastrointestinal Hormone; Recombinant Proteins; Sequence Homology, Amino Acid; Swine; Tumor Cells, Cultured | 1996 |
Cellular effect of thermal neutron capture treatment using 10B1-para-boronophenylalanine: lethal effect on melanoma cells with different degrees of X-ray sensitivity.
Topics: Antibiotics, Antineoplastic; Bleomycin; Boron Compounds; Boron Neutron Capture Therapy; Humans; Melanoma; Phenylalanine; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1996 |
In vivo diagnosis of human malignant melanoma with positron emission tomography using specific melanoma-seeking 18F-DOPA analogue.
Topics: Boron; Boron Compounds; Brain; Brain Neoplasms; Fluorine Radioisotopes; Humans; Isotopes; Lymphatic Metastasis; Melanoma; Phenylalanine; Tomography, Emission-Computed | 1997 |
Melanin-concentrating hormone binding sites in human SVK14 keratinocytes.
Topics: Amino Acid Sequence; Animals; Binding Sites; Carcinoma, Squamous Cell; Cell Line, Transformed; Cell Membrane; Humans; Hypothalamic Hormones; Iodine Radioisotopes; Keratinocytes; Melanins; Melanoma; Molecular Sequence Data; Neuroglia; PC12 Cells; Phenylalanine; Pituitary Hormones; Radioligand Assay; Rats; Receptors, Pituitary Hormone; Tumor Cells, Cultured; Tyrosine | 1997 |
Influence of tyrosine and phenylalanine limitation of cytotoxicity of chimeric TGF-alpha toxins on B16BL6 murine melanoma in vitro.
Topics: Animals; Antineoplastic Agents; Carrier Proteins; Cell Membrane; Culture Media; Epidermal Growth Factor; Heparin; Melanoma; Mice; Phenylalanine; Proteoglycans; Recombinant Fusion Proteins; Transforming Growth Factor alpha; Tumor Cells, Cultured; Tyrosine | 1998 |
Focal adhesion kinase-dependent apoptosis of melanoma induced by tyrosine and phenylalanine deficiency.
Topics: Animals; Apoptosis; Calcium; Cell Adhesion Molecules; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; G1 Phase; Humans; Intracellular Fluid; Melanoma; Melanoma, Experimental; Mice; Phenylalanine; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-myc; Resting Phase, Cell Cycle; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tyrosine | 1999 |
Pharmacokinetics of 10B-p-boronophenylalanine in tumours, skin and blood of melanoma patients: a study of boron neutron capture therapy for malignant melanoma.
Topics: Adult; Aged; Aged, 80 and over; Boron Compounds; Boron Neutron Capture Therapy; Female; Humans; Male; Melanoma; Middle Aged; Phenylalanine; Skin; Skin Neoplasms; Time Factors | 1999 |
Uptake and washout of borocaptate sodium and borono-phenylalanine in cultured melanoma cells: a multi-nuclear NMR study.
Topics: Animals; Biological Transport; Borohydrides; Boron Compounds; Culture Media; Melanoma; Mice; Nuclear Magnetic Resonance, Biomolecular; Perfusion; Phenylalanine; Radiation-Sensitizing Agents; Signal Transduction; Sulfhydryl Compounds; Tumor Cells, Cultured | 2000 |
Dual control of melanogenesis and melanoma growth: overview molecular to clinical level and the reverse.
Topics: Animals; Boron Compounds; Humans; Indolequinones; Indoles; Melanins; Melanoma; Melanosis; Phenylalanine; Quinones; Skin Pigmentation; Subcellular Fractions | 2000 |
Inhibition of B16BL6 melanoma invasion by tyrosine and phenylalanine deprivation is associated with decreased secretion of plasminogen activators and increased plasminogen activator inhibitors.
Topics: Animals; Cell Adhesion; Culture Media, Conditioned; Melanoma; Mice; Neoplasm Invasiveness; Phenylalanine; Plasminogen Activators; Plasminogen Inactivators; Tissue Plasminogen Activator; Tumor Cells, Cultured; Tyrosine; Urokinase-Type Plasminogen Activator | 1999 |
Decreased tissue plasminogen activator and increased plasminogen activator inhibitors and increased activator protein-1 and specific promoter 1 are associated with inhibition of invasion in human A375 melanoma deprived of tyrosine and phenylalanine.
Topics: Cell Adhesion; Culture Media, Conditioned; Fibroblasts; Humans; Infant; Melanoma; Neoplasm Invasiveness; Phenylalanine; Plasminogen Activators; Plasminogen Inactivators; Skin; Sp1 Transcription Factor; Tissue Plasminogen Activator; Transcription Factor AP-1; Tumor Cells, Cultured; Tyrosine; Urokinase-Type Plasminogen Activator | 2001 |
Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma.
Topics: beta Catenin; Cell Nucleus; Codon; Cytoplasm; Cytoskeletal Proteins; DNA Mutational Analysis; Exons; Humans; Immunohistochemistry; Melanoma; Mutation; Phenylalanine; Polymorphism, Single-Stranded Conformational; Sequence Analysis, DNA; Serine; Skin Neoplasms; Trans-Activators; Transcription, Genetic | 2001 |
Evaluation of the genotoxic effects of the boron neutron capture reaction in human melanoma cells using the cytokinesis block micronucleus assay.
Topics: Animals; Boron; Boron Compounds; Boron Neutron Capture Therapy; Cell Division; Cell Line; Cells, Cultured; Cricetinae; Drug Carriers; Fast Neutrons; Humans; Isotopes; Melanoma; Micronucleus Tests; Phenylalanine; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 2001 |
Specific amino acid deficiency alters the expression of genes in human melanoma and other tumor cell lines.
Topics: Blotting, Western; Breast Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Male; MAP Kinase Kinase 4; MAP Kinase Signaling System; Melanoma; Mitogen-Activated Protein Kinase Kinases; Phenylalanine; Phosphorylation; Prostatic Neoplasms; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Tyrosine | 2001 |
Neutron capture therapy of intracerebral melanoma: enhanced survival and cure after blood-brain barrier opening to improve delivery of boronophenylalanine.
Topics: Animals; Blood-Brain Barrier; Boron Compounds; Boron Neutron Capture Therapy; Bradykinin; Brain Neoplasms; Humans; Mannitol; Melanoma; Osmosis; Phenylalanine; Radiation-Sensitizing Agents; Rats; Rats, Nude | 2002 |
Acceptability and tolerance of a low tyrosine and phenylalanine diet in patients with advanced cancer -- a pilot study.
Topics: Adult; Aged; Breast Neoplasms; Depression; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nutritional Status; Phenylalanine; Pilot Projects; Quality of Life; Treatment Outcome; Tryptophan; Tyrosine | 2002 |
Activation of caspases and cleavage of Bid are required for tyrosine and phenylalanine deficiency-induced apoptosis of human A375 melanoma cells.
Topics: Amino Acid Chloromethyl Ketones; Amino Acids, Aromatic; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Blotting, Western; Carrier Proteins; Caspase Inhibitors; Caspases; Cysteine Proteinase Inhibitors; Cytochrome c Group; Fas Ligand Protein; fas Receptor; Humans; Ligands; Melanoma; Membrane Glycoproteins; Mitochondria; Models, Biological; Phenylalanine; Time Factors; Tumor Cells, Cultured; Tyrosine; Ubiquinone | 2002 |
Phenylalanine hydroxylase in melanoma cells.
Topics: Animals; Cell Line; Chromatography; Electrophoresis, Polyacrylamide Gel; Fenclonine; Hemadsorption; In Vitro Techniques; Melanoma; Mice; Monophenol Monooxygenase; Phenylalanine; Phenylalanine Hydroxylase; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase | 1978 |
Effect of dietetric factors on the growth of malignant melanomas.
Topics: Animals; Choroid Neoplasms; Cricetinae; Female; Humans; Melanoma; Phenylalanine; Tyrosine | 1977 |
A patient with malignant melanoma treated with a phenylalanine/tyrosine free diet.
Topics: Choroid Neoplasms; Humans; Male; Melanoma; Middle Aged; Phenylalanine; Tyrosine | 1977 |
Mammalian melanocytes do not use phenylalanine for melanin synthesis.
Topics: Animals; Cell Line; Cricetinae; Cycloheximide; Leucine; Melanins; Melanocytes; Melanoma; Phenylalanine; Pronase; Thiouracil; Tyrosine | 1977 |
Microwave hyperthermia, chemotherapy, and Co-60 radiation in the treatment of hamster melanoma [proceedings].
Topics: Animals; Cobalt Radioisotopes; Cricetinae; Diathermy; Melanoma; Neoplasm Transplantation; Neoplasms, Experimental; p-Fluorophenylalanine; Phenylalanine; Radioisotope Teletherapy | 1977 |
Regional perfusion for recurrent malignant melanoma of the extremities.
Topics: Adult; Aged; Chemotherapy, Cancer, Regional Perfusion; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Phenylalanine | 1977 |
Some biological properties and an in vivo evaluation of tyrosine phenol-lyase on growth of B-16 melanoma.
Topics: Animals; Female; Lactate dehydrogenase-elevating virus; Lyases; Male; Melanoma; Mice; Neoplasms, Experimental; Phenylalanine; Tyrosine; Tyrosine Phenol-Lyase | 1976 |
[Lethal effect of boron neutron capture reaction on human uveal melanoma cells in culture incubated with borophenylalanine].
Topics: Boron Compounds; Boron Neutron Capture Therapy; Cell Death; Culture Media; Humans; Melanoma; Phenylalanine; Tumor Cells, Cultured; Uveal Neoplasms | 1992 |
L-tyrosine-binding proteins on melanoma cells.
Topics: Animals; Antibodies; Blotting, Western; Carbon Radioisotopes; Chromatography, Affinity; Cricetinae; Levodopa; Melanoma; Molecular Weight; Monophenol Monooxygenase; Phenylalanine; Protein Binding; Tumor Cells, Cultured; Tyrosine | 1991 |
In situ detection of cutaneous melanoma by prompt gamma-ray spectrometry using melanoma-seeking 10B-dopa analogue.
Topics: Aged; Animals; Boron; Boron Compounds; Cricetinae; Disease Models, Animal; Female; Humans; Isotopes; Male; Melanoma; Mesocricetus; Phenylalanine; Skin Neoplasms; Spectrometry, Gamma; Time Factors | 1990 |
Boron neutron capture therapy for cancer.
Topics: Alpha Particles; Animals; Antibodies, Monoclonal; Boron; Boron Compounds; Brain Neoplasms; Glioblastoma; Humans; Immunotoxins; Isotopes; Melanoma; Mice; Neoplasms; Neutrons; Phenylalanine; Radiation Dosage | 1990 |
Response of natural killer cells from dietary tyrosine- and phenylalanine-restricted mice to biological response modifiers.
Topics: Animals; Antigen-Antibody Complex; Female; Food, Formulated; Immunologic Deficiency Syndromes; Interleukin-2; Killer Cells, Natural; Lymphopenia; Male; Melanoma; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Phenylalanine; Poly I-C; Specific Pathogen-Free Organisms; Tyrosine | 1988 |
Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy.
Topics: Animals; Boron Compounds; Mammary Neoplasms, Experimental; Melanins; Melanoma; Mice; Mice, Inbred BALB C; Neutrons; Phenylalanine; Stereoisomerism; Tissue Distribution | 1987 |
Interaction between specific dietary factors and experimental chemotherapy of metastatic melanoma.
Topics: Animals; Ascorbic Acid; Diet; Female; Levodopa; Lung Neoplasms; Melanoma; Mice; Mice, Inbred Strains; Phenylalanine; Tyrosine | 1986 |
Modulation of peroxidation in murine melanoma by dietary tyrosine-phenylalanine restriction, levodopa methylester chemotherapy, and sodium ascorbate supplementation.
Topics: Animals; Ascorbic Acid; Diet; Female; Levodopa; Lipid Peroxides; Liver; Malondialdehyde; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Phenylalanine; Tyrosine | 1985 |
The effect of a phenylalanine and tyrosine restricted diet on elemental balance studies and plasma aminograms of patients with disseminated malignant melanoma.
Topics: Adult; Amino Acids; Elements; Female; Food, Formulated; Humans; Male; Melanoma; Middle Aged; Patient Compliance; Phenylalanine; Tyrosine | 1985 |
Fluorometry of a DOPA peptide and its thioether.
Topics: Carbon Isotopes; Catechol Oxidase; Catechols; Chromatography, Paper; Cysteine; Dihydroxyphenylalanine; Dipeptides; Ethers; Fluorescence; Fluorometry; Melanoma; Peptides; Phenylalanine; Pigments, Biological; Spectrophotometry; Sulfhydryl Reagents; Sulfur; Tyrosine | 1971 |
[Nucleic acid and protein synthesis in hamster melanoma under the action of drugs. II. In vivo studies of protein synthesis in hamster melanoma following treatment with proflavin, chloramphenicol and D-penicillamine].
Topics: Acridines; Animals; Cell Nucleus; Chloramphenicol; Cricetinae; Melanoma; Mitochondria; Neoplasm Proteins; Neoplasms, Experimental; Penicillamine; Phenylalanine; Ribosomes; Stereoisomerism; Tritium | 1970 |
[Metabolism of malignant melanomas. Biochemical studies].
Topics: Adenosine Triphosphatases; Animals; Carbon Isotopes; Cricetinae; DNA, Neoplasm; Electron Transport Complex IV; Isoleucine; Leucine; Melanoma; Mitochondria; Neoplasms, Experimental; Phenylalanine; Skin Neoplasms | 1972 |
Effect on growth and structure of transplantable malignant melanomas of the Syrian golden hamster (Mesocricetus auratus) by depletion of phenylalanine and tyrosine in the diet and by inhibition of tyrosinase. Brief report.
Topics: Animals; Catechol Oxidase; Copper; Cricetinae; Cytoplasmic Granules; Diet; Genitalia; Hair; Melanocytes; Melanoma; Microscopy, Electron; Neoplasm Transplantation; Penicillamine; Phenylalanine; Pigmentation; Tyrosine | 1974 |
Reduced intake of phenylalanine and tyrosine as treatment of choroidal malignant melanoma.
Topics: Choroid Neoplasms; Dietary Proteins; Female; Humans; Melanins; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Phenylalanine; Remission, Spontaneous; Tyrosine; Ultrasonics; Vision, Ocular; Visual Fields | 1974 |
The influence of phenylalanine- and tyrosine-low diet on the growth and structure of transplantable malignant melanomas of the Syrian golden hamster (Mesocricetus auratus).
Topics: Amino Acids; Animals; Cricetinae; Cytoplasm; Dietary Proteins; Genitalia; Hair; Macrophages; Melanins; Melanocytes; Melanoma; Microscopy, Electron; Neoplasm Transplantation; Neoplasms, Experimental; Phenylalanine; Skin; Skin Neoplasms; Transplantation, Homologous; Tyrosine | 1974 |
Melanocytic neoplasms.
Topics: Dihydroxyphenylalanine; Epinephrine; Humans; Melanins; Melanocytes; Melanoma; Mustard Compounds; Neoplasm Metastasis; Neurons; Phenylalanine; Pigments, Biological; Skin Neoplasms; Tyrosine | 1974 |
An oligomeric hydroxyphenylalanine in malignant melanoma: a new type of melanogen.
Topics: Chromatography; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Melanoma; Oligopeptides; Phenylalanine; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet | 1974 |
Melanomas of vulva and vagina.
Topics: Adult; Aged; Cyclophosphamide; Female; Humans; Imidazoles; Lymph Node Excision; Lymphatic Metastasis; Melanoma; Middle Aged; Pelvis; Phenylalanine; Vaginal Neoplasms; Vulvar Neoplasms | 1973 |
The effect of a phenylalanine-tyrosine low diet on the growth and morphology of transplantable malignant melanomas of the Syrian golden hamster (Mesocricetus auratus).
Topics: Animals; Cell Transformation, Neoplastic; Copper; Cricetinae; Diet; Hair; Melanins; Melanocytes; Melanoma; Microscopy, Electron; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Phenylalanine; Pigmentation Disorders; Protein Deficiency; Skin; Skin Neoplasms; Transplantation, Homologous; Tyrosine | 1973 |
Altered amino acid concentrations accompanying suppression of malignancy of mouse melanoma cells by 5-bromodeoxyuridine.
Topics: Alanine; Amino Acids; Animals; Asparagine; Bromodeoxyuridine; Cells, Cultured; Glutamates; Glutamine; Glycine; Lysine; Melanoma; Methionine; Mice; Neoplasm Proteins; Ornithine; Phenylalanine; Pigmentation; Proline; Serine; Threonine; Valine | 1974 |
Experience with 1-phenylalanine mustard dihydrochloride in isolation-perfusion of extremities for malignant melanoma.
Topics: Alkylating Agents; Amputation, Surgical; Chemotherapy, Cancer, Regional Perfusion; Chlorides; Extremities; Female; Humans; Male; Melanoma; Mustard Compounds; Neoplasm Metastasis; Phenylalanine; Prognosis; Retrospective Studies; Skin Neoplasms; Skin Transplantation | 1971 |
In vitro growth inhibition of S-91 mouse melanomas by tyrosinase substrate analogs with and without L-cysteine.
Topics: Animals; Catechol Oxidase; Chemical Phenomena; Chemistry; Cysteine; In Vitro Techniques; Melanoma; Mice; Neoplasms, Experimental; Phenylalanine; Tyrosine | 1967 |
Oxidation of phenolic compounds by Mycobacterium leprae and inhibition of phenolase by substrate analogues and copper chelators.
Topics: Animals; Basidiomycota; Catechol Oxidase; Chelating Agents; Copper; Humans; Melanoma; Mice; Mycobacterium; Mycobacterium leprae; Phenols; Phenylalanine; Tyrosine | 1968 |
[Inhibitory effects of proflavine on the incorporation of DNA, RNA, and protein precursors in hamster melanoma].
Topics: Animals; Cell Nucleus; Cricetinae; DNA, Neoplasm; Female; Flavins; Liver; Melanoma; Mitochondria; Neoplasms, Experimental; Phenylalanine; RNA, Neoplasm; Thymine Nucleotides; Tritium; Uracil Nucleotides | 1972 |
Evidence for proflavine sensitive proteins in malignant hamster melanoma.
Topics: Amino Acids; Animals; Carbon Isotopes; Cricetinae; Cycloheximide; Electrophoresis, Disc; Flavins; Liver; Melanoma; Microsomes; Mitochondria; Mitochondria, Liver; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Experimental; Phenylalanine; Protein Biosynthesis | 1971 |
The effect of DNA repair inhibitors on e response of tumors treated with x-ray and alkylating agents.
Topics: Alkylating Agents; Animals; Bone Marrow; Caffeine; Chloroquine; Cricetinae; Cyclophosphamide; DNA; Leukocyte Count; Leukocytes; Melanoma; Nitrogen Mustard Compounds; Phenylalanine; Plasmacytoma | 1971 |
Pancreatic concentration of 125-I-labeled phenylalanine in mice.
Topics: Animals; Carbon Isotopes; Injections; Iodine; Iodine Isotopes; Male; Melanoma; Mice; Pancreas; Phenylalanine | 1969 |
Effects of low phenylalanine-tyrosine diets on S91 mouse melanomas.
Topics: Animals; Diet; Melanins; Melanoma; Mice; Neoplasms, Experimental; Phenylalanine; Sarcoma, Experimental; Tyrosine | 1966 |
Effects of reducing the phenylalanine-tyrosine intake of patients with advanced malignant melanoma.
Topics: Adult; Blood; Diet Therapy; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Phenylalanine; Skin Neoplasms; Tyrosine | 1966 |
Incidence and significance of melanogenuria.
Topics: Chromatography, Paper; Cyclophosphamide; Female; Hepatomegaly; Humans; Indoles; Male; Melanins; Melanoma; Phenylalanine; Spectrophotometry; Urine | 1966 |